The increasing prevalence of Alzheimer’s Disease (AD), and the costs of the drugs emerging for its treatment, together pose the question of how to evaluate these drugs in economic terms. We examine two approaches, first, an outline proposal [1] examining the requirements of a cost-effectiveness analysis of AD drugs; as it is defined, there exist severe problems in the areas of quality of life m...

We evaluated the role of several proteins that are likely to be involved in alzheimers disease (AD) and type 2 diabetes mellitus (T2DM). By employing multiple sequence alignment using Clustalw tool, we have constructed a phylogenetic tree based on the functional protein sequences extracted form NCBI. The phylogram was constructed using neighbor joining algorithm. Our bioinformatic analysis repo...